Sio Gene Therapies (SIOX) S-8 Registration of securities for employees

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Axovant Science Ltd. of our report dated June 6, 2016 relating to the financial statements, which appears in Axovant Sciences Ltd.'s Annual Report on Form 10‑K for the year ended March 31, 2018.

/s/ PricewaterhouseCoopers LLP

Florham Park, New Jersey

August 16, 2018